Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Read our press release: To view or add a comment, sign in The data Sanofi announced today marks a defining moment for the alpha-1 antitrypsin deficiency (#AATD) community
For solid dosage forms with strength ratios of 1:2, 1:3, and 1:4 or higher, the price decreases by 18%, 24%, and 30%, respectively
For Phase 1, that is 0.25mg
These participants also tended to walk faster following treatment, suggesting improved physical function
Medication is working as expected Seems to be working well
US$ 21.43
US$ 29.58
US$ 24.97
US$ 22.76
US$ 29.01
US$ 23.75
US$ 22.44
/product/42/083935/1.jpg?0295)
US$ 29.96
US$ 26.53
US$ 26.22
